Hypoglycemic events may trigger acute ischemic stroke within 30 days in those with diabetes: a case-crossover study
Makam S, Stein LK, Dhamoon MS
Stroke. Pub. online 22 Nov 2024.
Leggi
Breaking news
EMA: Updated advice to minimise risks of interaction between weight loss medicine Mysimba and opioids
15/11/2024
Leggi
AIFA: Classificazione del medicinale per uso umano, a base di Semaglutide «Rybelsus», nuove confezioni 1,5 mg – 4 mg – 9 mg in apposita sezione denominata classe C (Determina n. 655/2024)
11/11/2024
Leggi
Ministero della Salute: LINEE DI INDIRIZZO SULL’ATTIVITÀ FISICA. Revisione delle raccomandazioni per le persone con diabete mellito e per le persone sottoposte a trapianto e nuove raccomandazioni per le persone con patologie muscolo-scheletriche
11/11/2024
Leggi
Effects of tirzepatide on the clinical trajectory of patients with heart failure, a preserved ejection fraction, and obesity
Zile MR, Borlaug BA, Kramer CM, et al.
Circulation. Pub. online 18 Nov 2024.
Leggi
Intensive blood-pressure control in patients with type 2 diabetes
Bi Y, Li M, Liu Y, et al.
N Engl J Med. Pub. online 16 Nov 2024.
Leggi
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, et al.
Eur Heart J. 2024:ehae780.
Leggi
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Galderisi A, Sims EK, Evans-Molina C, et al.
Diabetologia. Pub. online 19 Nov 2024.
Leggi
Results from a randomized trial of intensive glucose management using CGM versus usual care in hospitalized adults with type 2 diabetes: the TIGHT study
Hirsch IB, Draznin B, Buse JB, et al.
Diabetes Care. 2024:dc241779.
Leggi
Alternative LDL cholesterol-lowering strategy vs high-intensity statins in atherosclerotic cardiovascular disease: a systematic review and individual patient data meta-analysis
Lee YJ, Hong BK, Yun KH, et al.
JAMA Cardiol. 2024:e243911.
Leggi